{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:08:07Z","timestamp":1790233687550,"version":"4.1.0"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVES:<\/jats:title>\n                  <jats:p>Intrauterine devices (IUDs) are increasingly being used in adolescents and nulliparous women for contraception. Levonorgestrel IUDs also have beneficial effects on bleeding and pain. Although they are recommended for menstrual suppression in adolescents with disabilities, there are limited data on their use in this population. Our objective is to describe the characteristics and experiences of levonorgestrel IUD use in nulliparous children, adolescents, and young adults with physical, intellectual, and developmental disabilities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>A retrospective chart review was conducted for all nulliparous patients ages \u226422 with physical, intellectual, or developmental disabilities who had levonorgestrel IUDs placed between July 1, 2004, and June 30, 2014, at a tertiary-care children\u2019s hospital. Descriptive statistical analysis and survival analysis were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>In total, 185 levonorgestrel IUDs were placed in 159 patients with disabilities. The mean age was 16.3 (3.3; range of 9\u201322) years. Only 4% had ever been sexually active; 96% of IUDs were inserted in the operating room. IUD continuation rate at 1 year was 95% (95% confidence interval: 93%\u2013100%) and at 5 years was 73% (95% confidence interval: 66%\u201383%). The amenorrhea rate was \u223c60% throughout the duration of IUD use among those with available follow-up data. Side effects and complications were \u22643%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>In this study, we provide evidence for the therapeutic benefit and safety of levonorgestrel IUD use in adolescents and young adults with physical, intellectual, and developmental disabilities. It should be considered as a menstrual management and contraceptive option for this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2020-0016","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T12:27:57Z","timestamp":1595507277000},"source":"Crossref","is-referenced-by-count":32,"title":["Intrauterine Device Use in Adolescents With Disabilities"],"prefix":"10.1542","volume":"146","author":[{"given":"Beth I.","family":"Schwartz","sequence":"first","affiliation":[{"name":"Division of Pediatric and Adolescent Gynecology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Alexander","sequence":"additional","affiliation":[{"name":"Division of Pediatric and Adolescent Gynecology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley L.","family":"Breech","sequence":"additional","affiliation":[{"name":"Division of Pediatric and Adolescent Gynecology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"issue":"1","key":"2021120914555954900_B1","first-page":"48","article-title":"Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial [published correction appears in Contraception. 2011;84(1):112]","volume":"83","author":"Shaaban","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"2021120914555954900_B2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/AOG.0b013e3181ec622b","article-title":"Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial [published correction appears in Obstet Gynecol. 2010;116(4):999]","volume":"116","author":"Kaunitz","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021120914555954900_B3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.contraception.2010.07.010","article-title":"Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up","volume":"83","author":"Chi","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"2021120914555954900_B4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/AOG.0b013e31824264c3","article-title":"Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial","volume":"119","author":"Tanmahasamut","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2021120914555954900_B5","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.contraception.2006.12.008","article-title":"Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea","volume":"75","author":"Bahamondes","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"2021120914555954900_B6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpag.2005.03.002","article-title":"Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at The Hospital for Sick Children, Toronto","volume":"18","author":"Dizon","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2, pt 1","key":"2021120914555954900_B7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/AOG.0000000000000387","article-title":"Menstrual and reproductive issues in adolescents with physical and developmental disabilities","volume":"124","author":"Quint","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021120914555954900_B8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.contraception.2017.10.007","article-title":"Pregnancy outcomes associated with extended use of the 52-mg 20 \u03bcg\/day levonorgestrel-releasing intrauterine system beyond 60 months: a chart review of 776 women in Brazil","volume":"97","author":"Bahamondes","year":"2018","journal-title":"Contraception"},{"issue":"6","key":"2021120914555954900_B9","doi-asserted-by":"crossref","first-page":"586.e1","DOI":"10.1016\/j.ajog.2017.01.036","article-title":"Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration","volume":"216","author":"McNicholas","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021120914555954900_B10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(01)00302-X","article-title":"Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years","volume":"65","author":"Hidalgo","year":"2002","journal-title":"Contraception"},{"issue":"3","key":"2021120914555954900_B11","first-page":"561","article-title":"The levonorgestrel-releasing intrauterine system: safety, efficacy, and patient acceptability","volume":"5","author":"Beatty","year":"2009","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"2021120914555954900_B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"US medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2021120914555954900_B13","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jpag.2019.04.007","article-title":"Hormonal contraceptives, intrauterine devices, gonadotropin-releasing hormone analogues and testosterone: menstrual suppression in special adolescent populations","volume":"32","author":"Pradhan","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"2021120914555954900_B14","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/AOG.0000000000001585","article-title":"Committee opinion no. 668: menstrual manipulation for adolescents with physical and developmental disabilities","volume":"128","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Adolescent Health Care","year":"2016","journal-title":"Obstet Gynecol"},{"key":"2021120914555954900_B15","volume-title":"Medical Eligibility Criteria for Contraceptive Use","author":"World Health Organization","year":"2015","edition":"5th ed"},{"issue":"2","key":"2021120914555954900_B16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0010-7824(88)90035-2","article-title":"The analysis of menstrual bleeding patterns: a review","volume":"38","author":"Belsey","year":"1988","journal-title":"Contraception"},{"issue":"5","key":"2021120914555954900_B17","doi-asserted-by":"crossref","first-page":"440.e8","DOI":"10.1016\/j.ajog.2018.12.008","article-title":"Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis","volume":"220","author":"Sergison","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"8796","key":"2021120914555954900_B18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"issue":"6","key":"2021120914555954900_B19","doi-asserted-by":"crossref","first-page":"600.e1","DOI":"10.1016\/j.ajog.2018.09.033","article-title":"Experience with intrauterine device insertion in never sexually active adolescents: a retrospective cohort study","volume":"219","author":"Kebodeaux","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2021120914555954900_B20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.contraception.2008.12.001","article-title":"A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents","volume":"79","author":"Paterson","year":"2009","journal-title":"Contraception"},{"issue":"3","key":"2021120914555954900_B21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpag.2012.01.005","article-title":"Retrospective review of intrauterine device in adolescent and young women","volume":"25","author":"Alton","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"21","key":"2021120914555954900_B22","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120914555954900_B23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0000000000000144","article-title":"Effects of age, parity, and device type on complications and discontinuation of intrauterine devices","volume":"123","author":"Aoun","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2021120914555954900_B24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-0528.2009.02372.x","article-title":"The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities","volume":"117","author":"Pillai","year":"2010","journal-title":"BJOG"},{"issue":"3","key":"2021120914555954900_B25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jadohealth.2013.04.014","article-title":"Trends in menstrual concerns and suppression in adolescents with developmental disabilities","volume":"53","author":"Kirkham","year":"2013","journal-title":"J Adolesc Health"},{"issue":"1","key":"2021120914555954900_B26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpag.2013.08.010","article-title":"Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities","volume":"27","author":"Savasi","year":"2014","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"2021120914555954900_B27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpag.2012.05.005","article-title":"Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay","volume":"25","author":"Hillard","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"2021120914555954900_B28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jpag.2016.06.004","article-title":"Uterine length in adolescents with developmental disability: are ultrasound examinations necessary before insertion of the levonorgestrel intrauterine system?","volume":"29","author":"Whyte","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"2021120914555954900_B29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jpag.2006.05.013","article-title":"Clinic opinions regarding IUCD use in adolescents","volume":"19","author":"Lacy","year":"2006","journal-title":"J Pediatr Adolesc Gynecol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-0016\/1080330\/peds_20200016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-0016\/1080330\/peds_20200016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T03:59:05Z","timestamp":1639108745000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/146\/2\/e20200016\/77018\/Intrauterine-Device-Use-in-Adolescents-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,1]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2020-0016","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"article-number":"e20200016"}}